In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance recommendations, barriers to implementation, emerging biomarkers in development, and unmet needs in hepatocellular carcinoma surveillance. Presenters:David E. Kaplan, MD, MScAssociate ProfessorPerelman School of MedicineChief, Hepatology Section Division of Gastroenterology and Hepatology University of PennsylvaniaDirector of HepatologyCorporal Michael J. Crescenz VA Medical CenterPhiladelphia, PennsylvaniaTamar Taddei, MDProfessor Section of Digestive Diseases Department of Internal MedicineYale School of Medicine Chief, GI Section VA Connecticut Healthcare SystemWest Haven, Connecticut

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related